SWM
BIO icon

SeaCrest Wealth Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

SeaCrest Wealth Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-53
Closed -$26K – 721
2022
Q2 		$26K Buy
+53
New +$27.6K ﹤0.01% 1384
2019
Q2 		– Sell
-36
Closed -$11K – 661
2019
Q1 		$11K Buy
36
+5
+16% +$1.35K ﹤0.01% 1486
2018
Q4 		$7K Sell
31
-1
-3% -$268 ﹤0.01% 1583
2018
Q3 		$10K Hold
32
– – ﹤0.01% 1640
2018
Q2 		$9K Sell
32
-8
-20% -$2.21K ﹤0.01% 1644
2018
Q1 		$10K Hold
40
– – ﹤0.01% 1567
2017
Q4 		$10K Buy
+40
New +$9.69K ﹤0.01% 1583

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return